Skip to main content
Log in

The role of nonacid reflux in laryngopharyngeal reflux diseases

  • Laryngology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Objective

To analyze the role of nonacid reflux in laryngopharyngeal reflux diseases (LPRD).

Methods

From January 2014 to April 2019, 344 patients associated with LPRD underwent 24-h multichannel intraluminal impedance–pH monitoring, and their reflux symptom index (RSI) and reflux finding score (RFS) were recorded. The numbers of acid, weakly acidic and alkaline reflux events in the laryngopharynx were counted, and the consistency analysis of the results with the results of the RSI and RFS was conducted.

Results

Among the 344 patients, nonacid reflux events accounted for 74.1% (1367/1845) of the all reflux events. There were 111 patients with ≥ 3 acid reflux events, 218 patients with ≥ 3 any kinds of reflux events, and 257 patients with positive results of RSI or RFS. Taking the results of the RSI and or RFS as a reference, the sensitivity, specificity and consistency test Kappa value for the diagnosis of LPRD according to the existence of ≥ 3 acid reflux events were 41.2%, 94.2% and 0.228, respectively. With the existence of three or more all kinds of reflux events as the standard, the sensitivity, specificity and consistency test Kappa value were 76.7%, 74.7% and 0.449, respectively.

Conclusion

The nonacid reflux events account for the highest proportion of laryngopharyngeal reflux events, and the consistency of the results of RSI and or RFS with all reflux events is higher than that with only acid reflux events, that indicates nonacid reflux may play an important role in LPRD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adhami T, Goldblum JR, Richter JE, Vaezi MF (2004) The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 99:2098–2106

    Article  Google Scholar 

  2. Sung MW, Roh JL, Park BJ et al (2003) Bile acid induces Cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux. Laryngoscope 113:1059–1106

    Article  CAS  Google Scholar 

  3. Lee JS, Jung AR, Park JM et al (2018) Comparison of characteristics according to reflux type in patients with laryngopharyngeal reflux. Clin Exp Otorhinolaryngol 11(2):141–145. https://doi.org/10.21053/ceo.2017.00577

    Article  PubMed  Google Scholar 

  4. Blumin JH, Merati AL, Toohill RJ (2008) Duodenogastroesophageal reflux and its effect on extraesophageal tissues: a review. Ear Nose Throat J 87(4):234–237

    Article  Google Scholar 

  5. Koufman JA, Amin MR, Panetti M (2000) Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 123(4):385–388. https://doi.org/10.1067/mhn.2000.109935

    Article  CAS  PubMed  Google Scholar 

  6. Wang J, Li J, Li X et al (2015) Application of 24-hour multichannel intraluminal impedance in combination with pH monitoring for the diagnosis of laryngopharyngeal reflux: a pilot study. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 50(7):564–568

    PubMed  Google Scholar 

  7. Smit CF, Tan J, Devriese PP et al (1998) Ambulatory pH measurements at the upper oesophageal sphincter. Laryngoscope 108(2):299–302

    Article  CAS  Google Scholar 

  8. Kahrilas PJ (2007) Clarifying the parameters of nonacid reflux. Gastroenterol Hepatol 3(11):821–822

    Google Scholar 

  9. Aldhahrani A, Powell J, Ladak S et al (2018) The potential role of bile acids in acquired laryngotracheal stenosis. Laryngoscope 128(9):2029–2033

    Article  CAS  Google Scholar 

  10. Ali MS, Parikh S, Chater P et al (2013) Bile acids in laryngopharyngeal refluxate: will they enhance or attenuate the action of pepsin? Laryngoscope 123(2):434–439

    Article  CAS  Google Scholar 

  11. Sereg-Bahar M, Jerin A, Hocevar-Boltezar I (2015) Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer. Radiol Oncol 49(1):59–64

    Article  CAS  Google Scholar 

  12. Galli J, Calò L, Agostino S et al (2003) Bile reflux as possible risk factor in laryngopharyngeal inflammatory and neoplastic lesions. Acta Otorhinolaryngol Ital 23(5):377–382

    CAS  PubMed  Google Scholar 

  13. Blumin JH, Merati AL, Toohill RJ (2008) Duodenogastroesophageal reflux and its effect on extraesophageal tissues: a review. Ear Nose Throat J 87(4):234–237

    Article  Google Scholar 

  14. Lechien JR, Akst LM, Hamdan AL et al (2019) Evaluation and management of laryngopharyngeal reflux disease: state of the art review. Otolaryngol Head Neck Surg 60(5):762–782

    Article  Google Scholar 

  15. Strugala V, Kennington EJ, Campbell RJ et al (2005) Inhibition of pepsin activity by alginates in vitro and the effect of epimerization. Int J Pharm 304(1–2):40–50. https://doi.org/10.1016/j.ijpharm.2005.07.017

    Article  CAS  PubMed  Google Scholar 

  16. Strugala V, Avis J, Jolliffe IG et al (2009) The role of an alginate suspension on pepsin and bile acids—key aggressors in the gastric refluxate Does this have implications for the treatment of gastro-oesophageal reflux disease? J Pharm Pharmacol 61(8):1021–1028. https://doi.org/10.1211/jpp/61.08.0005

    Article  CAS  PubMed  Google Scholar 

  17. McGlashan JA, Johnstone LM, Sykes J et al (2009) The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 266(2):243–251. https://doi.org/10.1007/s00405-008-0708-7

    Article  PubMed  Google Scholar 

  18. Tseng WH, Tseng PH, Wu JF et al (2018) Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease. Laryngoscope 128(10):2252–2260. https://doi.org/10.1002/lary.27111

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jinrang Li.

Ethics declarations

Conflict of interest

All the authors do not have any conflicts.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Wang, J., Wu, M. et al. The role of nonacid reflux in laryngopharyngeal reflux diseases. Eur Arch Otorhinolaryngol 277, 2813–2819 (2020). https://doi.org/10.1007/s00405-020-06015-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-020-06015-6

Keywords

Navigation